For the first target addressed in the partnership, the two companies reported the successful delivery of AI-designed, ...

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US.

Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD (L)-1xVEGF bispecific antibodies for cancer?

Review the current AstraZeneca PLC ADR (AZN:XNAS) dividend yield and history to decide if AZN is the best investment for you.

Find out if AstraZeneca PLC ADR (AZN:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the company's ...